Lab Items - Department of Health Research

Antihuman MPO FITC Cat No 340580,DAPI BV421 Cat No 564907,Antihuman Elastase PE Cat No 568908,Antih

Goods
Qty:43

Tender Timeline

Tender Issue
May 9, 2025 at 2:35 PM
Corrigendum
May 30, 2025 at 04:22 PM
Bid Extended to June 16, 2025 at 03:00 PM

Tender Title: Lab Items
Reference Number: 495956a6
Issuing Authority: Department of Health Research, Ministry of Health and Family Welfare

The Lab Items tender, referenced as 495956a6, is initiated by the Department of Health Research under the Ministry of Health and Family Welfare. This procurement process aims to acquire a specified range of laboratory materials essential for health research and clinical applications. The scope encompasses a variety of items, including but not limited to Antihuman MPO FITC, DAPI BV421, Antihuman Elastase PE, and various antibody reagents vital for diagnostic and research work.

Scope of Work and Objectives

The primary objective of this tender is to source high-quality lab items that meet the technical specifications required for research. The intended use of these items includes various biochemical and molecular assays, therefore, they need to conform to the highest standards of quality and reliability.

Eligibility Criteria

To participate in this tender, bidders must fulfill specific eligibility criteria, which include:

  • Registration as a legal entity.
  • Previous experience in supplying similar lab items.
  • Compliance with applicable standards and certifications in the region.

Technical Requirements

The lab items must meet specified technical requirements to ensure their effectiveness. For instance, each item must come with laboratory-grade certification and must comply with international standards for quality. Detailed descriptions of each product including catalog numbers will be provided in the tender documents.

Financial Requirements

Participants should ensure their financial stability, evidenced by recent financial statements. Additional documentation may be required to assess financial capacity and stability.

Document Submission Details

All required submissions must be completed electronically through the designated procurement platform. Bidders must ensure their submissions include the necessary technical specifications, financial documents, and any other required data by the submission deadline. No late submissions will be accepted.

Special Provisions

Micro, Small, and Medium Enterprises (MSEs) as well as startups may be afforded certain benefits under this tender, encouraging a diverse range of suppliers to participate. Specific guidelines regarding these provisions will be detailed in the tender documentation.

Evaluation Process

The evaluation of submitted bids will be conducted based on several criteria, including technical compliance, financial viability, and past performance. The tender evaluation process adopts a transparent approach to ensure fairness and integrity.

Delivery Locations

Delivery of the lab items will be primarily directed to designated research facilities and hospitals as specified in the tender documents. Bidders should be prepared for timely logistics and effective distribution channels.

Contact Information

For further information and clarifications, bidders can refer to the contact details provided in the official tender documents. It is crucial to communicate through the recommended channels to ensure prompt responses.

Conclusion

This tender for Lab Items under the specified reference and authority aims to enhance the capacity of health research through the acquisition of quality laboratory materials. Suppliers with the capability to meet technical and financial conditions are encouraged to participate actively in this opportunity. Interested parties should maintain vigilance regarding submission timelines and requirements to ensure a successful bidding process.


Tender BOQ Items

19 Items
1.

Antihuman MPO FITC Cat No 340580

Please refer schedule 1 of attached PDF

Qty:2
Unit:vial
15
2.

DAPI BV421 Cat No 564907

Please refer schedule 1 of attached PDF

Qty:2
Unit:vial
15
3.

Antihuman Elastase PE Cat No 568908

Please refer schedule 1 of attached PDF

Qty:2
Unit:vial
15
4.

Antihuman CD63 PEcy7 Cat No 561982

Please refer schedule 1 of attached PDF

Qty:2
Unit:vial
15
5.

Antihuman CD66b Percp cy 5 point 5 Cat No 562254

Please refer schedule 1 of attached PDF

Qty:2
Unit:vial
15
6.

Antihuman CD35 BV605 Cat No 744276

Please refer schedule 1 of attached PDF

Qty:2
Unit:vial
15
7.

Antihuman CD16 BV786 Cat No 563689

Please refer schedule 1 of attached PDF

Qty:2
Unit:vial
15
8.

Antihuman CD11B APC Cat No 550019

Please refer schedule 1 of attached PDF

Qty:2
Unit:vial
15
9.

Antihuman IFN-g PE Cy7 Cat No 557643

Please refer schedule 2 of attached PDF

Qty:3
Unit:vial
15
10.

5ml Round bottom FACS tubes Cat No 352054

Please refer schedule 2 of attached PDF

Qty:2
Unit:vial
15
11.

CD28 CD49d Costimulatory Reagent Cat no 347690

Please refer schedule 2 of attached PDF

Qty:2
Unit:vial
15
12.

Fixation Permeabilization Solution Kit Cat no 554714

Please refer schedule 2 of attached PDF

Qty:2
Unit:vial
15
13.

BD Lysis solution Cat no 349202

Please refer schedule 2 of attached PDF

Qty:2
Unit:vial
15
14.

Compensation beads Cat no 569991

Please refer schedule 2 of attached PDF

Qty:1
Unit:vial
15
15.

Antihuman CD3 APC H7 Cat no 560176

Please refer schedule 3 of attached PDF

Qty:3
Unit:vial
15
16.

Antihuman CD4 PE Cat no 566910

Please refer schedule 3 of attached PDF

Qty:3
Unit:vial
15
17.

Antihuman CD8 FITC Cat no 570817

Please refer schedule 3 of attached PDF

Qty:3
Unit:vial
15
18.

Antihuman IL2 BV421 Cat no 562914

Please refer schedule 3 of attached PDF

Qty:3
Unit:vial
15
19.

Antihuman TNFa APC Cat no 340534

Please refer schedule 3 of attached PDF

Qty:3
Unit:vial
15

General Information

Item Category
Antihuman MPO FITC Cat No 340580 , DAPI BV421 Cat No 564907 , Antihuman Elastase PE Cat No 568908 , Antihuman CD63 PEcy7 Cat No 561982 , Antihuman CD66b Percp cy 5 point 5 Cat No 562254 , Antihuman CD35 BV605 Cat No 744276 , Antihuman CD16 BV786 Cat No 563689 , Antihuman CD11B APC Cat No 550019 , Antihuman IFN-g PE Cy7 Cat No 557643 , 5ml Round bottom FACS tubes Cat No 352054 , CD28 CD49d Costimulatory Reagent Cat no 347690 , Fixation Permeabilization Solution Kit Cat no 554714 , BD Lysis solution Cat no 349202 , Compensation beads Cat no 569991 , Antihuman CD3 APC H7 Cat no 560176 , Antihuman CD4 PE Cat no 566910 , Antihuman CD8 FITC Cat no 570817 , Antihuman IL2 BV421 Cat no 562914 , Antihuman TNFa APC Cat no 340534

Financial Information

OEM Average Turnover
₹5.00 Lakh (s)
Minimum Turnover
₹5.00 Lakh (s)
Bid Offer Validity
180 (Days)
Past Performance
50 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Group wise evaluation
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7823954.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Corrigendum Updates

Bid Extended to June 16, 2025 at 03:00 PMModified on May 30, 2025 at 04:22 PM
Bid Opening June 16, 2025 at 03:30 PM

Frequently Asked Questions

The qualification requirements include being a registered entity with proof of legal compliance. Bidders must demonstrate experience in supplying lab items that comply with the specified technical standards. This may include submission of prior purchase orders or agreements demonstrating relevant experience in a similar capacity.

The lab items must adhere to established technical specifications, which include compliance with laboratory-grade certifications. Each item should possess a unique catalog number and meet international quality standards. Documentation attesting to these specifications must accompany submissions to ensure they meet the necessary criteria for evaluation.

Potential bidders should be prepared to submit an Earnest Money Deposit (EMD) as part of their proposal. The exact amount will be outlined in the tender documents, and bidders are advised to refer to these specifications for detailed instructions on the EMD process, including mode of payment and refund conditions.

Submissions must be made electronically through the designated procurement platform. Bidders should follow the provided guidelines for uploading documents and submitting proposals. Ensure that all required certifications and financial documents are included in a single submission to avoid disqualification.

Micro, Small, and Medium Enterprises (MSEs) and startups are encouraged to participate in this tender, as they may qualify for certain benefits such as reduced bidding requirements or financial incentives. Detailed provisions regarding how MSEs and startups can benefit from this tender will be specified in the documents accompanying the tender announcement.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders